EP Vantage

Pfizer (NYSE: PFE) has come to a settlement with Israel's Teva Pharmaceutical Industries (NYSE: TEVA), that will allow Teva to to launch a generic version of the anti-impotency drug Viagra in late 2017. While most of the agreement's terms remain confidential, Pfizer says Teva will pay a royalty...